0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NGS-based RNA-seq Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-16M2307
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global NGS based RNA seq Market Insights and Forecast to 2028
BUY CHAPTERS

Global NGS-based RNA-seq Market Research Report 2025

Code: QYRE-Auto-16M2307
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NGS-based RNA-seq Market Size

The global market for NGS-based RNA-seq was valued at US$ 1944 million in the year 2024 and is projected to reach a revised size of US$ 4071 million by 2031, growing at a CAGR of 11.3% during the forecast period.

NGS-based RNA-seq Market

NGS-based RNA-seq Market

Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
This report aims to provide a comprehensive presentation of the global market for NGS-based RNA-seq, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-based RNA-seq.
The NGS-based RNA-seq market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NGS-based RNA-seq market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGS-based RNA-seq companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of NGS-based RNA-seq Market Report

Report Metric Details
Report Name NGS-based RNA-seq Market
Accounted market size in year US$ 1944 million
Forecasted market size in 2031 US$ 4071 million
CAGR 11.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • High-Throughput Sequencing
  • Third-Generation Sequencing Technology
Segment by Application
  • Hospitals and Clinics
  • Biopharma Companies
  • Government Agencies
  • Academic and Research Organizations
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of NGS-based RNA-seq company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NGS-based RNA-seq Market growing?

Ans: The NGS-based RNA-seq Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the NGS-based RNA-seq Market size in 2031?

Ans: The NGS-based RNA-seq Market size in 2031 will be US$ 4071 million.

Who are the main players in the NGS-based RNA-seq Market report?

Ans: The main players in the NGS-based RNA-seq Market are Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen

What are the Application segmentation covered in the NGS-based RNA-seq Market report?

Ans: The Applications covered in the NGS-based RNA-seq Market report are Hospitals and Clinics, Biopharma Companies, Government Agencies, Academic and Research Organizations, Other

What are the Type segmentation covered in the NGS-based RNA-seq Market report?

Ans: The Types covered in the NGS-based RNA-seq Market report are High-Throughput Sequencing, Third-Generation Sequencing Technology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-seq Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 High-Throughput Sequencing
1.2.3 Third-Generation Sequencing Technology
1.3 Market by Application
1.3.1 Global NGS-based RNA-seq Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Government Agencies
1.3.5 Academic and Research Organizations
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-seq Market Perspective (2020-2031)
2.2 Global NGS-based RNA-seq Growth Trends by Region
2.2.1 Global NGS-based RNA-seq Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NGS-based RNA-seq Historic Market Size by Region (2020-2025)
2.2.3 NGS-based RNA-seq Forecasted Market Size by Region (2026-2031)
2.3 NGS-based RNA-seq Market Dynamics
2.3.1 NGS-based RNA-seq Industry Trends
2.3.2 NGS-based RNA-seq Market Drivers
2.3.3 NGS-based RNA-seq Market Challenges
2.3.4 NGS-based RNA-seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-seq Players by Revenue
3.1.1 Global Top NGS-based RNA-seq Players by Revenue (2020-2025)
3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2020-2025)
3.2 Global NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NGS-based RNA-seq Revenue
3.4 Global NGS-based RNA-seq Market Concentration Ratio
3.4.1 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-seq Revenue in 2024
3.5 Global Key Players of NGS-based RNA-seq Head office and Area Served
3.6 Global Key Players of NGS-based RNA-seq, Product and Application
3.7 Global Key Players of NGS-based RNA-seq, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-seq Breakdown Data by Type
4.1 Global NGS-based RNA-seq Historic Market Size by Type (2020-2025)
4.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2026-2031)
5 NGS-based RNA-seq Breakdown Data by Application
5.1 Global NGS-based RNA-seq Historic Market Size by Application (2020-2025)
5.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NGS-based RNA-seq Market Size (2020-2031)
6.2 North America NGS-based RNA-seq Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NGS-based RNA-seq Market Size by Country (2020-2025)
6.4 North America NGS-based RNA-seq Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-based RNA-seq Market Size (2020-2031)
7.2 Europe NGS-based RNA-seq Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NGS-based RNA-seq Market Size by Country (2020-2025)
7.4 Europe NGS-based RNA-seq Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-seq Market Size (2020-2031)
8.2 Asia-Pacific NGS-based RNA-seq Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NGS-based RNA-seq Market Size by Region (2020-2025)
8.4 Asia-Pacific NGS-based RNA-seq Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-based RNA-seq Market Size (2020-2031)
9.2 Latin America NGS-based RNA-seq Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NGS-based RNA-seq Market Size by Country (2020-2025)
9.4 Latin America NGS-based RNA-seq Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-seq Market Size (2020-2031)
10.2 Middle East & Africa NGS-based RNA-seq Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NGS-based RNA-seq Market Size by Country (2020-2025)
10.4 Middle East & Africa NGS-based RNA-seq Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-seq Introduction
11.1.4 Illumina Revenue in NGS-based RNA-seq Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Introduction
11.2.4 Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences Of California
11.3.1 Pacific Biosciences Of California Company Details
11.3.2 Pacific Biosciences Of California Business Overview
11.3.3 Pacific Biosciences Of California NGS-based RNA-seq Introduction
11.3.4 Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2020-2025)
11.3.5 Pacific Biosciences Of California Recent Development
11.4 Qaigen
11.4.1 Qaigen Company Details
11.4.2 Qaigen Business Overview
11.4.3 Qaigen NGS-based RNA-seq Introduction
11.4.4 Qaigen Revenue in NGS-based RNA-seq Business (2020-2025)
11.4.5 Qaigen Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Introduction
11.5.4 F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies NGS-based RNA-seq Introduction
11.6.4 Agilent Technologies Revenue in NGS-based RNA-seq Business (2020-2025)
11.6.5 Agilent Technologies Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Details
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Introduction
11.7.4 Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2020-2025)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer NGS-based RNA-seq Introduction
11.8.4 Perkinelmer Revenue in NGS-based RNA-seq Business (2020-2025)
11.8.5 Perkinelmer Recent Development
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Details
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific NGS-based RNA-seq Introduction
11.9.4 Eurofins Scientific Revenue in NGS-based RNA-seq Business (2020-2025)
11.9.5 Eurofins Scientific Recent Development
11.10 Gatc Biotech
11.10.1 Gatc Biotech Company Details
11.10.2 Gatc Biotech Business Overview
11.10.3 Gatc Biotech NGS-based RNA-seq Introduction
11.10.4 Gatc Biotech Revenue in NGS-based RNA-seq Business (2020-2025)
11.10.5 Gatc Biotech Recent Development
11.11 Macrogen
11.11.1 Macrogen Company Details
11.11.2 Macrogen Business Overview
11.11.3 Macrogen NGS-based RNA-seq Introduction
11.11.4 Macrogen Revenue in NGS-based RNA-seq Business (2020-2025)
11.11.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global NGS-based RNA-seq Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of High-Throughput Sequencing
 Table 3. Key Players of Third-Generation Sequencing Technology
 Table 4. Global NGS-based RNA-seq Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global NGS-based RNA-seq Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global NGS-based RNA-seq Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global NGS-based RNA-seq Market Share by Region (2020-2025)
 Table 8. Global NGS-based RNA-seq Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global NGS-based RNA-seq Market Share by Region (2026-2031)
 Table 10. NGS-based RNA-seq Market Trends
 Table 11. NGS-based RNA-seq Market Drivers
 Table 12. NGS-based RNA-seq Market Challenges
 Table 13. NGS-based RNA-seq Market Restraints
 Table 14. Global NGS-based RNA-seq Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global NGS-based RNA-seq Market Share by Players (2020-2025)
 Table 16. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2024)
 Table 17. Ranking of Global Top NGS-based RNA-seq Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by NGS-based RNA-seq Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of NGS-based RNA-seq, Headquarters and Area Served
 Table 20. Global Key Players of NGS-based RNA-seq, Product and Application
 Table 21. Global Key Players of NGS-based RNA-seq, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global NGS-based RNA-seq Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global NGS-based RNA-seq Revenue Market Share by Type (2020-2025)
 Table 25. Global NGS-based RNA-seq Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global NGS-based RNA-seq Revenue Market Share by Type (2026-2031)
 Table 27. Global NGS-based RNA-seq Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global NGS-based RNA-seq Revenue Market Share by Application (2020-2025)
 Table 29. Global NGS-based RNA-seq Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global NGS-based RNA-seq Revenue Market Share by Application (2026-2031)
 Table 31. North America NGS-based RNA-seq Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America NGS-based RNA-seq Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America NGS-based RNA-seq Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe NGS-based RNA-seq Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe NGS-based RNA-seq Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe NGS-based RNA-seq Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific NGS-based RNA-seq Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific NGS-based RNA-seq Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific NGS-based RNA-seq Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America NGS-based RNA-seq Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America NGS-based RNA-seq Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America NGS-based RNA-seq Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa NGS-based RNA-seq Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa NGS-based RNA-seq Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa NGS-based RNA-seq Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Illumina Company Details
 Table 47. Illumina Business Overview
 Table 48. Illumina NGS-based RNA-seq Product
 Table 49. Illumina Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 50. Illumina Recent Development
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific NGS-based RNA-seq Product
 Table 54. Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Pacific Biosciences Of California Company Details
 Table 57. Pacific Biosciences Of California Business Overview
 Table 58. Pacific Biosciences Of California NGS-based RNA-seq Product
 Table 59. Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 60. Pacific Biosciences Of California Recent Development
 Table 61. Qaigen Company Details
 Table 62. Qaigen Business Overview
 Table 63. Qaigen NGS-based RNA-seq Product
 Table 64. Qaigen Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 65. Qaigen Recent Development
 Table 66. F. Hoffmann-La Roche Company Details
 Table 67. F. Hoffmann-La Roche Business Overview
 Table 68. F. Hoffmann-La Roche NGS-based RNA-seq Product
 Table 69. F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 70. F. Hoffmann-La Roche Recent Development
 Table 71. Agilent Technologies Company Details
 Table 72. Agilent Technologies Business Overview
 Table 73. Agilent Technologies NGS-based RNA-seq Product
 Table 74. Agilent Technologies Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 75. Agilent Technologies Recent Development
 Table 76. Oxford Nanopore Technologies Company Details
 Table 77. Oxford Nanopore Technologies Business Overview
 Table 78. Oxford Nanopore Technologies NGS-based RNA-seq Product
 Table 79. Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 80. Oxford Nanopore Technologies Recent Development
 Table 81. Perkinelmer Company Details
 Table 82. Perkinelmer Business Overview
 Table 83. Perkinelmer NGS-based RNA-seq Product
 Table 84. Perkinelmer Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 85. Perkinelmer Recent Development
 Table 86. Eurofins Scientific Company Details
 Table 87. Eurofins Scientific Business Overview
 Table 88. Eurofins Scientific NGS-based RNA-seq Product
 Table 89. Eurofins Scientific Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 90. Eurofins Scientific Recent Development
 Table 91. Gatc Biotech Company Details
 Table 92. Gatc Biotech Business Overview
 Table 93. Gatc Biotech NGS-based RNA-seq Product
 Table 94. Gatc Biotech Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 95. Gatc Biotech Recent Development
 Table 96. Macrogen Company Details
 Table 97. Macrogen Business Overview
 Table 98. Macrogen NGS-based RNA-seq Product
 Table 99. Macrogen Revenue in NGS-based RNA-seq Business (2020-2025) & (US$ Million)
 Table 100. Macrogen Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. NGS-based RNA-seq Picture
 Figure 2. Global NGS-based RNA-seq Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global NGS-based RNA-seq Market Share by Type: 2024 VS 2031
 Figure 4. High-Throughput Sequencing Features
 Figure 5. Third-Generation Sequencing Technology Features
 Figure 6. Global NGS-based RNA-seq Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global NGS-based RNA-seq Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals and Clinics Case Studies
 Figure 9. Biopharma Companies Case Studies
 Figure 10. Government Agencies Case Studies
 Figure 11. Academic and Research Organizations Case Studies
 Figure 12. Other Case Studies
 Figure 13. NGS-based RNA-seq Report Years Considered
 Figure 14. Global NGS-based RNA-seq Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global NGS-based RNA-seq Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global NGS-based RNA-seq Market Share by Region: 2024 VS 2031
 Figure 17. Global NGS-based RNA-seq Market Share by Players in 2024
 Figure 18. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by NGS-based RNA-seq Revenue in 2024
 Figure 20. North America NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America NGS-based RNA-seq Market Share by Country (2020-2031)
 Figure 22. United States NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe NGS-based RNA-seq Market Share by Country (2020-2031)
 Figure 26. Germany NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific NGS-based RNA-seq Market Share by Region (2020-2031)
 Figure 34. China NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America NGS-based RNA-seq Market Share by Country (2020-2031)
 Figure 42. Mexico NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa NGS-based RNA-seq Market Share by Country (2020-2031)
 Figure 46. Turkey NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE NGS-based RNA-seq Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Illumina Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 51. Pacific Biosciences Of California Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 52. Qaigen Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 54. Agilent Technologies Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 55. Oxford Nanopore Technologies Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 56. Perkinelmer Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 57. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 58. Gatc Biotech Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 59. Macrogen Revenue Growth Rate in NGS-based RNA-seq Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS